Influenza News and Research

Latest Influenza News and Research

Axolotl's two EHR systems receive ONC-ATCB certification

Axolotl Corp. announced that two of its electronic health record systems - Axolotl EHR, version 7 and Elysium EMR Lite - have received Office of the National Coordinator for Health IT Authorized Testing and Certification Body 2011/2012 certifications in accordance with Eligible Provider certification criteria adopted by the U.S. Department of Health and Human Services.

1 Mar 2011

FDA approves Forest Labs' Daliresp to treat COPD

Forest Laboratories, Inc. announced today that Daliresp was approved by the U.S. Food and Drug Administration as a treatment to reduce the risk of chronic obstructive pulmonary disease exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

1 Mar 2011

Novavax announces agreement to license VLP vaccine technology to LGLS

Novavax, Inc. announced today an agreement to license its proprietary, recombinant virus-like-particle vaccine technology to LG Life Sciences, Ltd.

1 Mar 2011

Cancer drug may help combat flu

Ever get a flu shot and still get the flu? If so, there's new hope for flu-free winters in the years to come thanks to a new discovery by researchers who found that a drug called DMXAA, originally developed as anti-tumor agent, enhances the ability of flu vaccines to ward off this deadly virus.

1 Mar 2011

Social networking websites can increase risky sexual behaviors in homeless youth: New study

A new UCLA AIDS Institute study suggests that the use of social networking websites by homeless youth can lead to an increase in risky sexual behaviors. But interestingly, homeless kids who used these sites were also more likely to have been tested for sexually transmitted infections and to be better informed about preventing such infections and HIV.

1 Mar 2011

New nasal vaccine holds promise against both Alzheimer's disease and stroke

One in eight Americans will fall prey to Alzheimer's disease at some point in their life, current statistics say. Because Alzheimer's is associated with vascular damage in the brain, many of them will succumb through a painful and potentially fatal stroke.

1 Mar 2011

HHS awards two contracts to accelerate flu vaccine availability

U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.

28 Feb 2011

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

Regeneron Pharmaceuticals, Inc. announced that in a second Phase 3 study (PRE-SURGE 2) in gout patients initiating allopurinol therapy, ARCALYST (rilonacept) met the primary and all secondary study endpoints. The primary endpoint was the number of gout flares per patient over the 16-week treatment period.

28 Feb 2011

BioCryst receives HHS contract to complete peramivir Phase 3 study in patients with influenza

BioCryst Pharmaceuticals, Inc. announced that it has been awarded a $55.0 million contract modification by the U.S. Department of Health & Human Services intended to fund to completion the Phase 3 development of its neuraminidase inhibitor, intravenous peramivir, for the treatment of patients hospitalized with influenza.

25 Feb 2011

MedInformatix, University Radiology work together to implement Federal Government-certified technology

University Radiology Group, New Jersey's largest provider of subspecialty radiology and teleradiology services, is working with MedInformatix Inc. to implement Federal Government-certified technology that enables medical practices to achieve Stage 1 meaningful use goals and objectives under The American Recovery and Reinvestment Act for Health Information Technology.

25 Feb 2011

New vaccine offers hope against Hepatitis C

Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark.

24 Feb 2011

Multi-national consortium develops new approaches to cure the flu

Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project “FLUCURE” supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses. The consortium also joined Vironova AB and Beactica AB (Sweden), Pike Pharma GmbH (Switzerland) and university-based research groups from Italy, Germany, Bulgaria, Lithuania, and the Netherlands.

23 Feb 2011

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza

Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.

23 Feb 2011

Scientists receive HHS grant to investigate DSC127 in treatment of skin injuries linked with radiation exposure

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that researchers who invented DSC127 have been awarded a $4.5 million, 16-month grant by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority to investigate preclinically the use of DSC127 in the treatment of skin injuries associated with acute radiation exposure.

23 Feb 2011

'Day on Deadly Killers'

Experts from Europe, the US and Asia will present their research results and discuss how new therapeutical approaches against infectious diseases may look like.

22 Feb 2011

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Health Canada has approved FLUAD, a Novartis seasonal flu vaccine for adults 65 years and older. Canadian seniors are the hardest hit of all age groups by seasonal influenza and account for 90 per cent of influenza deaths and 70 per cent of hospitalizations.

22 Feb 2011

Henry Schein fourth quarter net sales increase 15.1% to $7.5 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 25, 2010.

22 Feb 2011

Vical extends relationship with U.S. NMRC for emerging disease vaccine platform

Vical Incorporated announced today that the company has extended its relationship with the U.S. Naval Medical Research Center to develop its platform technology for the rapid development and production of vaccines against emerging infectious diseases.

22 Feb 2011

Johnson & Johnson completes cash tender for Crucell shares, declares offer unconditional

Johnson & Johnson and Crucell N.V. today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. and has declared the offer unconditional.

22 Feb 2011

Influenza News and Research

Latest Influenza News and Research

Axolotl's two EHR systems receive ONC-ATCB certification

FDA approves Forest Labs' Daliresp to treat COPD

Novavax announces agreement to license VLP vaccine technology to LGLS

Cancer drug may help combat flu

Social networking websites can increase risky sexual behaviors in homeless youth: New study

New nasal vaccine holds promise against both Alzheimer's disease and stroke

HHS awards two contracts to accelerate flu vaccine availability

Regeneron's ARCALYST meets primary, secondary endpoints in second Phase 3 gout flare study

BioCryst receives HHS contract to complete peramivir Phase 3 study in patients with influenza

MedInformatix, University Radiology work together to implement Federal Government-certified technology

New vaccine offers hope against Hepatitis C

Multi-national consortium develops new approaches to cure the flu

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza

Scientists receive HHS grant to investigate DSC127 in treatment of skin injuries linked with radiation exposure

'Day on Deadly Killers'

Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval

Henry Schein fourth quarter net sales increase 15.1% to $7.5 billion

Vical extends relationship with U.S. NMRC for emerging disease vaccine platform

Johnson & Johnson completes cash tender for Crucell shares, declares offer unconditional

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Influenza News and Research

Latest Influenza News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in